Brexpiprazole Oral Soluble Film(Sichuan Kelun)

布瑞哌唑口溶膜（四川科伦）

Report date: 2026/04/08 09:45:02

Base Information

Drug NameBrexpiprazole Oral Soluble Film(Sichuan Kelun)
Drug Alias Namebrexpiprazol布瑞哌唑brexpiprazole依匹哌唑brexpiprazolum +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonistsSerotonin 1a (5-HT1a) receptor agonistsDopamine D2 receptor agonists
TargetsSerotonin 2a (5-HT2a) receptorSerotonin 1a (5-HT1a) receptorDopamine D2 receptor
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsSchizophrenia
Approved Indications in ChinaSchizophrenia
Original Approved Country/TerritoryMainland China
Original Approved Date2026/03/17
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSichuan Kelun Pharmacy Institute Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSichuan Kelun Pharmacy Institute Co Ltd
Inactive CompaniesN/A
Active IndicationsSchizophrenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG